Kenvue Inc.
Price Chart
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $34.85B |
| Revenue | $15.29B |
| Net Income | $1.62B |
| Total Assets | $26.85B |
| Net Assets | $10.61B |
| Employees | 21,780 |
| Value | |
| P/E | 21.48x |
| P/B | 3.29x |
| PEG | 0.46x |
| P/S | 2.28x |
| EV/EBITDA | 13.02x |
| FCF Yield | 5.23% |
| Profitability | |
| ROE | 15.29% |
| ROA | 6.04% |
| Op. Margin | 19.62% |
| Revenue Growth | 4.49% |
| Earnings Growth | 47.20% |
| Financial Health | |
| Debt Ratio | 153.15% |
| Total Debt | $8.66B |
| FCF | $1.82B |
| Cash | $1.07B |
| Current Ratio | 0.98x |
| Net Debt/EBITDA | 2.33x |
| Dividend | |
| Div. Yield | 6.81% |
| Div. Growth | -89.71% |
| Performance | |
| 1Y Return | -12.14% |
| 1M Return | 5.83% |
| From 52W High | -17.94% |
| 1Y MDD | -41.20% |
| Trading | |
| Volume | 13,896,242 shares |
| Trading Value | $253M |
| Per Share | |
| EPS | $0.77 |
| BPS | $5.62 |
Company Info
Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral and baby care, women's health, wound care, and other essential health products; tampons; cosmetics; and vitamins and supplements. It sells its products under the Benadryl, Calpol, Motrin, Nicorette, Rhinocort, Tylenol, Zarbee's Naturals, and Zyrtec; Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Neutrogena, OGX, and Rogaine; BAND-AID, Carefree, Desitin, Johnson's, Listerine, o.b., and Stayfree; and ORSL, Clean & Clear, Versalie, Benylin, Daktarin, Imodium, Johnson's Baby, Johnson's Adult, Maui Moisture, Microlax, Motilium, Neosporin, Neostrata, Pepcid, Pulmicort, Regaine, Sudafed, and Visine/Vispring/Visclear brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.